1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Exenatide
Trade Name:
Bydureon
Manufacturer/Distributor:
AstraZeneca Canada
www.astrazeneca.ca
Classification:
Incretin mimetic
Antihyperglycemic agent
ATC Class:
A10BX - other blood glucose lowering drugs, excluding insulin
Status:
active
Notice of Compliance (yyyy/mm/dd):
2015/10/30
Date Marketed in Canada (yyyy/mm/dd):
2016/02/16
Presentation:
Injectable suspension: 2 mg/pen. DIN: 02448610
Comments:
Incretin mimetic in a suspension format for once weekly subcutaneous injection (differs from Byetta [exenatide] which is given twice daily). For treatment of type 2 diabetes.
Back to:
Drug Product Listings 
